Ortho Evra Patch
Submit form for Free Case Evaluation.
Ortho Evra Patch Press Room: Coming Soon.
On September 20, 2006, study results were released that confirmed previous reports of an increased risk of blood clots associated with Ortho Evra use versus oral contraceptives. The study found that the risk was two times the clot risk of oral contraceptive pills. While another study found that the risk was equal, previous calculations have put the blood clot risk for the patch at three times that of the pills. Johnson & Johnson announced it will update the Ortho Evra label with the results of the new studies. The FDA has also issued a warning about the new contraceptive patch study results.
Johnson & Johnson's Ortho Evra contraceptive patch contains higher levels of a hormone known to cause blood clots than average birth control pills, U.S. regulators warned. The U.S. Food and Drug Administration said on November 10, 2005 that the new label for the patch will include information about the higher levels of estrogen. Women who use Ortho Evra are exposed to 60 percent more estrogen than those who use the pill, the FDA said in its statement.
The Food and Drug Administration has received twenty-one reports of life-threatening blood clots and other ailments associated with Ortho Evra birth control patch use. The contraceptive patch, which has been aggressively marketed using Olympic athletes, sexy ads and fashion models, has been linked to the deaths of at least seventeen young American women over the past two years. Approximately 4 million women have used the Ortho Evra Patch since it went on sale in 2002. FDA records show that seventeen patch users between the ages of 17 and 30 have suffered fatal heart attacks, blood clots and possible strokes since August 2002.
If you or a loved one suffered a blood clots, heart attacks and/or stroke as a result of the Ortho Evra Patch, you may be entitled to a substantial recovery. Submit form for Free Case Evaluation.
BextraRashAttorney.com